Gulf International Bank (UK)’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,635
Closed -$1.63M 700
2022
Q3
$1.63M Sell
6,635
-104
-2% -$28.1K 0.03% 490
2022
Q2
$1.67M Hold
6,739
0.03% 505
2022
Q1
$2.23M Buy
6,739
+104
+2% +$32K 0.03% 471
2021
Q4
$2.38M Sell
6,635
-1,483
-18% -$501K 0.03% 469
2021
Q3
$2.64M Sell
8,118
-113
-1% -$38.3K 0.03% 480
2021
Q2
$2.57M Sell
8,231
-70
-0.8% -$21.5K 0.03% 504
2021
Q1
$2.65M Sell
8,301
-1,500
-15% -$480K 0.04% 471
2020
Q4
$3.18M Sell
9,801
-100
-1% -$27.7K 0.04% 437
2020
Q3
$2.74M Hold
9,901
0.04% 418
2020
Q2
$2.39M Hold
9,901
0.04% 441
2020
Q1
$1.44M Hold
9,901
0.03% 488
2019
Q4
$1.69M Hold
9,901
0.03% 548
2019
Q3
$1.76M Hold
9,901
0.03% 518
2019
Q2
$2.58M Hold
9,901
0.04% 433
2019
Q1
$2.83M Hold
9,901
0.05% 387
2018
Q4
$3.22M Sell
9,901
-4,300
-30% -$1.49M 0.06% 306
2018
Q3
$6.39M Buy
14,201
+400
+3% +$158K 0.08% 271
2018
Q2
$5.64M Buy
+13,801
New +$5M 0.07% 296

Other funds holding ABMD

Gulf International Bank (UK)'s ABMD Position: Q4 2022 in Review

Gulf International Bank (UK) sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,635 shares — an estimated $1.63M sold.

Gulf International Bank (UK) first reported a position in ABMD in Q2 2018 and held it in 18 quarters. The position peaked at $6.39M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Gulf International Bank (UK) reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Gulf International Bank (UK) sold 6,635 Abiomed Inc shares in Q4 2022, an estimated $1.63M.
  • Gulf International Bank (UK) first reported a position in Abiomed Inc in Q2 2018 and held it in 18 quarters.
  • Gulf International Bank (UK)'s Abiomed Inc position peaked at $6.39M in Q3 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Gulf International Bank (UK)'s 13F filing for Q4 2022, filed 8 Feb 2023.